|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-9-9
|
|
pubmed:abstractText |
Prostate cancer (PCa) is the most common malignancy in males in Western countries. Despite improvements in standard treatments such as surgery, radiotherapy, and chemotherapy, many patients still progress to advanced stages. Recent clinical trials have shown encouraging results regarding the application of angiogenic inhibitors in the treatment of angiogenesis-dependent diseases, paving the way for novel PCa therapies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1873-7560
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
418-26
|
|
pubmed:meshHeading |
pubmed-meshheading:20605315-Angiogenesis Inhibitors,
pubmed-meshheading:20605315-Animals,
pubmed-meshheading:20605315-Drug Screening Assays, Antitumor,
pubmed-meshheading:20605315-Fluorobenzenes,
pubmed-meshheading:20605315-Humans,
pubmed-meshheading:20605315-Male,
pubmed-meshheading:20605315-Mice,
pubmed-meshheading:20605315-Mice, SCID,
pubmed-meshheading:20605315-Neovascularization, Pathologic,
pubmed-meshheading:20605315-Prostatic Neoplasms,
pubmed-meshheading:20605315-Pyrimidines,
pubmed-meshheading:20605315-Sulfonamides,
pubmed-meshheading:20605315-Tumor Cells, Cultured,
pubmed-meshheading:20605315-Zebrafish
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.
|
|
pubmed:affiliation |
Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article
|
